Beauty Editor Donna Francis, 49, asks a trichologist for tips to help her eyelashes grow back to their full potential in ...

Tarsus Pharmaceuticals, Inc. upgraded to Strong Buy; Xdemvy's rapid US growth and unique market lead highlight big upside.

It is unclear if eye drops to reduce immune responses of the eye surface, such as topical corticosteroids and cyclosporine, have any effect on the signs and symptoms of blepharitis at 4 to 12 weeks.

Blepharitis, a prevalent chronic inflammatory eye condition, impacts the eyelid margins and is classified as anterior or posterior blepharitis. Key market drivers include a growing patient pool, aging ...

During the week, Bryan Wahl is the full-time general counsel for Tarsus Pharmaceuticals, one of Orange County’s standout ...

A new treatment is presented that eliminates the root cause of the disease and restores ocular surface health.

Treat scalp dandruff if present. Maintain good facial hygiene. Massage with medium pressure on highlighted area (see figure) ...

A severe case of misdiagnosis is revisited to show how careful evaluation led to recovery and renewed patient trust.

Xdemvy (lotilaner ophthalmic solution 0.25%) is a medicine designed to treat Demodex blepharitis, a common but often overlooked eye condition caused by microscopic insects called Demodex mites on the ...

Viatris's said on Friday that the trial of an ointment for people with blepharitis didn't meet its primary endpoint. The phase 3 study to evaluate the efficacy and safety of the ophthalmic ointment ...

PITTSBURGH, July 18, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that a randomized, double-masked, vehicle-controlled, Phase 3 study to evaluate the ...